JP2007525461A5 - - Google Patents

Download PDF

Info

Publication number
JP2007525461A5
JP2007525461A5 JP2006513416A JP2006513416A JP2007525461A5 JP 2007525461 A5 JP2007525461 A5 JP 2007525461A5 JP 2006513416 A JP2006513416 A JP 2006513416A JP 2006513416 A JP2006513416 A JP 2006513416A JP 2007525461 A5 JP2007525461 A5 JP 2007525461A5
Authority
JP
Japan
Prior art keywords
drug
delivery device
drug delivery
permeable polymeric
section
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006513416A
Other languages
English (en)
Japanese (ja)
Other versions
JP4898431B2 (ja
JP2007525461A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013172 external-priority patent/WO2004096151A2/en
Publication of JP2007525461A publication Critical patent/JP2007525461A/ja
Publication of JP2007525461A5 publication Critical patent/JP2007525461A5/ja
Application granted granted Critical
Publication of JP4898431B2 publication Critical patent/JP4898431B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006513416A 2003-04-29 2004-04-29 複数薬物の持続放出のための方法およびデバイス Expired - Lifetime JP4898431B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46631803P 2003-04-29 2003-04-29
US60/466,318 2003-04-29
US47357903P 2003-05-27 2003-05-27
US60/473,579 2003-05-27
PCT/US2004/013172 WO2004096151A2 (en) 2003-04-29 2004-04-29 Methods and devices for the sustained release of multiple drugs

Publications (3)

Publication Number Publication Date
JP2007525461A JP2007525461A (ja) 2007-09-06
JP2007525461A5 true JP2007525461A5 (enExample) 2007-10-18
JP4898431B2 JP4898431B2 (ja) 2012-03-14

Family

ID=33423604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006513416A Expired - Lifetime JP4898431B2 (ja) 2003-04-29 2004-04-29 複数薬物の持続放出のための方法およびデバイス

Country Status (8)

Country Link
US (7) US7833545B2 (enExample)
EP (1) EP1620060B1 (enExample)
JP (1) JP4898431B2 (enExample)
AT (1) ATE461681T1 (enExample)
AU (1) AU2004233997C1 (enExample)
CA (1) CA2523859C (enExample)
DE (1) DE602004026173D1 (enExample)
WO (1) WO2004096151A2 (enExample)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
EP1667619A4 (en) 2003-09-19 2007-10-10 Drugtech Corp PHARMACEUTICAL FEEDING SYSTEM
WO2006010097A2 (en) 2004-07-09 2006-01-26 The Population Council, Inc. Sustained release compositions containing progesterone receptor modulators
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US8057817B2 (en) * 2004-12-14 2011-11-15 Poly-Med, Inc. Intravaginal ringed mesh device and applicator therefor
EP2034984A4 (en) 2006-06-02 2013-03-06 Pear Tree Women S Health Care PROCESS FOR TREATING ATROPHIC VAGINITIS
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
US20080160065A1 (en) * 2006-07-12 2008-07-03 Janet Anne Halliday Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2672602C (en) 2006-12-18 2014-05-20 Electronic Dietary Foods Inc. Device for delivery of a substance
US20090118253A1 (en) * 2007-11-05 2009-05-07 Repros Therapeutics Inc. Compositions and methods for treating dysfunctional uterine bleeding
EP2057972A1 (en) * 2007-11-07 2009-05-13 N.V. Organon Intrauterine deposit
EP2062569B1 (en) * 2007-11-22 2011-05-11 Bayer Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
DK2359807T3 (en) 2008-02-04 2017-10-16 Ferring Bv Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
WO2010054296A2 (en) * 2008-11-07 2010-05-14 Combinent Biomedical Systems, Inc. Devices and methods for treating and/or preventing diseases
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
BR112012001353B8 (pt) 2009-07-21 2021-05-25 The Population Council Inc anel vaginal, e, método para fabricar um anel vaginal
EP3689364A1 (en) * 2010-02-08 2020-08-05 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer
US20110236462A1 (en) * 2010-03-28 2011-09-29 Shaked Ze Ev Intravaginal drug delivery device
AU2011256259A1 (en) 2010-05-17 2012-11-08 Novaer Holdings, Inc. Drug delivery devices for delivery of ocular therapeutic agents
JP2013535992A (ja) * 2010-06-22 2013-09-19 テバ ウィメンズ ヘルス インコーポレイテッド 抗コリン作動剤を含む膣内用デバイスおよびそれを作る方法
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
AU2011325975B2 (en) 2010-11-12 2015-11-26 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
KR101263916B1 (ko) 2011-01-11 2013-05-13 이장희 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법
DE202012012713U1 (de) * 2011-03-04 2014-01-23 Arstat, Inc. Intravaginale Arzneimittelabgabevorrichtung
JP6010120B2 (ja) 2011-07-15 2016-10-19 ウニベルシテイト ヘント 膣内送達システム
AU2012308317B2 (en) 2011-09-14 2017-01-05 Forsight Vision5, Inc. Ocular insert apparatus and methods
CA2848965A1 (en) * 2011-09-14 2013-03-21 Royer Biomedical, Inc. Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US20130166931A1 (en) * 2011-12-23 2013-06-27 Lsi Corporation Reducing power consumption of memory
CN103040090B (zh) * 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN102754907B (zh) 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
BR112014029131B1 (pt) 2012-05-31 2021-03-09 Allergan Pharmaceuticals International Limited cápsula de mucoadesivo
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
SI2911623T1 (sl) 2012-10-26 2019-12-31 Forsight Vision5, Inc. Oftalmični sistem za podaljšano sproščanje zdravila v oko
HK1211852A1 (en) 2012-11-02 2016-06-03 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
SI2982352T1 (sl) 2014-06-28 2018-12-31 Laboratorios Andromaco S.A. Cervikalni pesar, ki vsebuje progesteron za podaljšano, zakasnjeno in kontinuirano sproščanje, ki se uporablja za preprečevanje prezgodnjega poroda
CN105277633B (zh) * 2014-07-26 2017-06-23 浙江仙琚制药股份有限公司 一种炔诺酮衍生物及其中间体的杂质检测分析方法
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
EP3247327B1 (en) 2015-01-21 2019-08-07 Bayer Oy Drug delivery system comprising a non-steroidal anti-inflammatory (nsaid) and a progestogenic compound and methods for manufacturing
DK3250183T3 (da) * 2015-01-30 2024-07-22 Ligalli B V Vaginal lægemiddeltilførselsanordning
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
ES3009909T3 (en) * 2015-05-13 2025-03-31 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
GB201517523D0 (en) * 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction
US20190008804A1 (en) * 2016-01-12 2019-01-10 Repros Therapeutics Inc. Trans-Clomiphene and Progesterone Receptor Antagonist Combination Therapy for Treating Hormone-Dependent Conditions
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
GB201708224D0 (en) 2017-05-23 2017-07-05 Juniper Pharmaceuticals Uk Ltd Device
FR3070619B1 (fr) * 2017-09-01 2024-10-04 Ab7 Innovation Piece moulee monolithique en matrice multiple pour la diffusion d’actifs et son procede d’obtention
EP3700477B1 (en) 2017-10-27 2025-06-11 Axena Health, Inc. Devices, systems, and methods for training pelvic floor muscles
CN108186553B (zh) * 2018-02-13 2020-10-02 广东药科大学 一种黄体酮长效栓剂及其制备方法
EP3773542A1 (en) * 2018-04-10 2021-02-17 Li Galli B.V. Vaginal systemic drug delivery
CA3098551A1 (en) * 2018-04-27 2019-10-31 Evestra, Inc. Estrogen prodrugs and methods of administering estrogen prodrugs
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
AU2019275406B2 (en) 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
SG11202005949UA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
US20210000641A1 (en) * 2019-03-29 2021-01-07 Bridget Martell Eva segmented intravaginal rings containing progesterone
WO2021068239A1 (zh) * 2019-10-12 2021-04-15 国家卫生健康委科学技术研究所 用于黄体支持的阴道缓释给药系统及其制备方法与应用
CN115066239A (zh) * 2019-11-18 2022-09-16 戴尔生物科学公司 阴道内环装置
FR3107203B1 (fr) * 2020-02-14 2023-11-24 Ab7 Innovation Matrice solide composite pour la délivrance prolongée d’actifs
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
US12472148B2 (en) 2021-04-26 2025-11-18 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
WO2023031218A1 (en) 2021-08-31 2023-03-09 Ferring B.V. Diagnosis and treatment of ectopic endometriosis
JP2024547174A (ja) * 2021-12-30 2024-12-26 テレフレックス メディカル インコーポレイテッド 熱可塑性ポリマー組成物中の配合活性薬剤および製造方法
CN120569187A (zh) * 2023-01-09 2025-08-29 戴尔生物科学公司 用于激素替代疗法的方法和装置
WO2024155777A2 (en) 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2025174767A1 (en) * 2024-02-13 2025-08-21 Biraj Investments, Llc Highly loaded implantable devices with high tensile strength for drug delivery

Family Cites Families (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1945275U (de) * 1965-04-30 1966-09-01 Ortho Pharma Corp Intrauterine vorrichtung zur empfaengnisverhuetung.
US3454004A (en) * 1967-08-18 1969-07-08 Holland Rantos Co Inc Intrauterine contraceptive device
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
NL6903028A (enExample) 1969-02-26 1970-08-28
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3903880A (en) 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US3938515A (en) 1971-12-20 1976-02-17 Alza Corporation Novel drug permeable wall
US3708511A (en) 1972-01-18 1973-01-02 Organon Novel {66 -steroids of the oestrane series
NL7204025A (enExample) 1972-03-24 1973-09-26
US3780935A (en) 1972-07-10 1973-12-25 Lukacs & Jacoby Ass Serum separating method
NL7210262A (enExample) 1972-07-26 1974-01-29
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3963119A (en) 1973-10-13 1976-06-15 Lucaks And Jacoby Associates Serum separating apparatus
US4043928A (en) 1973-10-31 1977-08-23 Lukacs And Jacoby Associates Serum separating composition of matter
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4096860A (en) 1975-10-08 1978-06-27 Mclaughlin William F Dual flow encatheter
US3995633A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US3995634A (en) 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4219426A (en) 1976-03-19 1980-08-26 Organon Teknika B.V. Dialysis device
US4237885A (en) 1978-10-23 1980-12-09 Alza Corporation Delivery system with mated members for storing and releasing a plurality of beneficial agents
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4484559A (en) * 1982-03-01 1984-11-27 Mcdermott Incorporated Apparatus for removing material such as concrete from underwater pipelines
DE3214667C2 (de) 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US4629449A (en) * 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
NL8301035A (nl) 1983-03-23 1984-10-16 Organon Teknika Bv Macromoleculair materiaal met carbonylgroepen geschikt als sorbent voor stikstofverbindingen.
US4558996A (en) 1983-06-30 1985-12-17 Organon Teknika Corporation Easy load peristaltic pump
US4484599A (en) 1983-09-23 1984-11-27 Organon Teknika Corporation Pinch-type pressure- or flow-regulating valve
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4645502A (en) 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
SE8602666D0 (sv) 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
CA1331563C (en) 1987-08-03 1994-08-23 Gaylen M. Zentner Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
NZ228285A (en) 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5034229A (en) 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5002540A (en) 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5252334A (en) 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
HU208495B (en) 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
IE67345B1 (en) 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US5340585A (en) 1991-04-12 1994-08-23 University Of Southern California Method and formulations for use in treating benign gynecological disorders
US5211952A (en) 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
EP0566135A1 (en) 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Transmucosal composition comprising a peptide and a cytidine derivative
CA2098889A1 (en) 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
US5482702A (en) * 1993-04-27 1996-01-09 Church & Dwight Co., Inc. Hydrophilic polymer-coated microcrystallites of bicarbonate salt
JPH08512054A (ja) 1993-06-25 1996-12-17 アルザ・コーポレーション 経皮系におけるポリ−ｎ−ビニルアミドの含有
GB2282384B8 (en) 1993-08-18 1997-09-04 Europ Economic Community Drug delivery agents incorporating mitomycin
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
CN1135716A (zh) 1993-12-27 1996-11-13 阿克佐诺贝尔公司 经皮吸收的药用制剂
FR2717688B1 (fr) 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
FI97944C (fi) 1994-07-05 1997-03-25 Leiras Oy Vaikuttavaa ainetta luovuttava laite
US5681568A (en) 1994-08-19 1997-10-28 Cambridge Neuroscience, Inc. Device for delivery of substances and methods of use thereof
US5593965A (en) 1994-10-20 1997-01-14 Creighton University Anti-tumor effects of GnRH-III
IL116433A (en) 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
WO1996031197A1 (en) 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
WO1997002015A1 (en) * 1995-07-04 1997-01-23 Akzo Nobel N.V. Ring-shaped devices
FR2739032B1 (fr) 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6156331A (en) 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US6139873A (en) 1996-07-10 2000-10-31 Cedars-Sinai Medical Center Combined pharmaceutical estrogen-androgen-progestin
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
ES2221019T3 (es) 1996-10-31 2004-12-16 Takeda Chemical Industries, Ltd. Preparacion de liberacion mantenida.
US5985861A (en) 1996-11-04 1999-11-16 Columbia Laboratories, Inc. Progesterone for treating or reducing ischemia
JPH10138432A (ja) 1996-11-14 1998-05-26 Teijin Ltd 磁気テープ用二軸配向積層ポリエステルフィルム
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
JPH10279499A (ja) 1997-04-04 1998-10-20 Takeda Chem Ind Ltd 子宮粘膜適用製剤
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
AR012448A1 (es) 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
US6905701B2 (en) 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US5941844A (en) 1997-11-17 1999-08-24 Alza Corporation Method and device for controlling mammalian reproductive cycle
PT1736145E (pt) 1997-12-30 2012-03-16 Intarcia Therapeutics Inc Sistema de entrega de agente benéfico com obturador de membrana
USD442688S1 (en) 1998-01-28 2001-05-22 N.V. Organon Vaginal ring applicator
EP0940678A1 (en) 1998-03-02 1999-09-08 Akzo Nobel N.V. Analytical test device
US5945123A (en) 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
EP1100669B1 (en) 1998-05-01 2005-12-21 Duramed Pharmaceuticals, Inc. Method for injection molding manufacture of controlled release devices and controlled release device
US6218367B1 (en) 1998-09-15 2001-04-17 Organomed Corporation Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations
US6143314A (en) 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6159491A (en) 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
EP1142959A4 (en) 1999-08-25 2002-11-06 Dai Ichi Kogyo Seiyaku Co Ltd MOLDED RESIN COMPOSITION IN GEL FORM, CHEMICAL PRODUCT IN PACKAGED VOLATILE GEL, AND PROCESS FOR PRODUCING THE SAME.
US6264973B1 (en) 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
US7052714B1 (en) 1999-10-13 2006-05-30 Senju Pharmaceutical Co., Ltd Ophthalmic adhesive preparations for percutaneous adsorption
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US6687178B1 (en) * 2001-02-23 2004-02-03 Western Digital (Fremont), Inc. Temperature dependent write current source for magnetic tunnel junction MRAM

Similar Documents

Publication Publication Date Title
JP2007525461A5 (enExample)
CA2523859A1 (en) Methods and devices for the sustained release of multiple drugs
US4402695A (en) Device for delivering agent in vagina
US10532025B2 (en) Intrauterine delivery system for contraception
US4250611A (en) Process for making drug delivery device with reservoir
US4629449A (en) Vaginal dispenser for dispensing beneficial hormone
US4961931A (en) Method for the management of hyperplasia
AU2005271865B2 (en) Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea
AR066166A1 (es) Sistema de suministro de droga
AU2009317127B2 (en) Intravaginal delivery system and process for manufacturing it
RU2648827C2 (ru) Внутривлагалищное устройство для доставки лекарственного средства
JP2007502316A5 (enExample)
JP2005507874A (ja) 癌治療のための化学療法剤及び膜流出システム阻害剤の経膣送達
CN101827581A (zh) 用于递送大分子和水溶性药物的阴道内药物递送装置
MX2011001605A (es) Dispositivos intravaginales con un soporte rigido, metodos de fabricacion y usos de los mismos.
CN102215901A (zh) 用于治疗和/或预防疾病的装置和方法
RS55331B1 (sr) Postupak za kontracepciju po potrebi
WO2019200694A1 (zh) 一种宫腔内具备重新激活内膜基底层功能的弹性膜及其制备方法
Yan et al. Recent progress in advanced biomaterials for long-acting reversible contraception
US20190201418A1 (en) Treatment of uterine fibroids by intravaginal administration of a low dose of selective progesterone receptor modulator (sprm), anti-progestin, or anti-progestational agent
das Neves et al. Vaginal drug delivery
CA1143289A (en) Microparticle drug delivery system
CN202044643U (zh) 一种防治宫腔粘连的药物带膜支架
TW202320878A (zh) 用於遞送避孕藥之可再填充植入式裝置
US20130269706A1 (en) Barrel-shaped vaginal ring